4-Piperidinecarbonitrile hydrochloride → HCID 68808815, 화합물
반응식
Cl[C:2]1[CH:11]=[CH:10][C:9]2[C:8]([C:12]([NH:14][CH2:15][CH:16]3[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]3)=[O:13])=[C:7]([Cl:22])[CH:6]=[CH:5][C:4]=2[N:3]=1.Cl.[C:24]([CH:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1)#[N:25]>>[Cl:22][C:7]1[CH:6]=[CH:5][C:4]2[N:3]=[C:2]([N:29]3[CH2:30][CH2:31][CH:26]([C:24]#[N:25])[CH2:27][CH2:28]3)[CH:11]=[CH:10][C:9]=2[C:8]=1[C:12]([NH:14][CH2:15][CH:16]1[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]1)=[O:13]참가 물질
3
실험 절차
Prepared according to the method of example 51, using 2,6-dichloro-N-(cyclohexylmethyl)-5-quinolinecarboxamide Example 43(a)) (0.25 g), and 4-cyanopiperidine hydrochloride (0.25 g) to afford the title compound (0.27 g).
후처리
- customPrepared
출처 및 근거
- ORD 기록
- ord-edd62a653b534581960380a0f2b2a52f
- 출처 데이터셋
- uspto-grants-2008_08
- 특허 번호
- US07408065B2
반응 노트
불러오는 중…